Delivery Order SPE2DB20D1100-SPE2DB24FC3R5

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,652.80 firm fixed-price contract has a completion date of July 18, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider supplying medical products to federal government agencies, including military and veterans' healthcare systems. This award is...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $1,103.74, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 19, 2024. It is not associated with a set-aside designation. Amerisourcebergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,351.65 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,896.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 5, 2024 and was awarded on April 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024, with a total ceiling value of $1,425.43. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of December 5, 2024. No set-aside designation was used for this...
This federal contract award, valued at $3,940.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Testosterone Cypionate 200 mg/mL medication, a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,970.00 firm fixed-price Delivery Order contract is for the supply of "TESTOSTERONE CYP 200 MG/MLML" and has an ultimate completion date of June 3, 2024. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.54 firm fixed-price delivery order contract is for the provision of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of June 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Testosterone Cypionate 200 mg/mL medication. The $2,295.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.83 delivery order covers the supply of testosterone cypionate 200 mg/mL medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. The...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3R5
    Delivery Order

This federal contract award is for the supply of testosterone cypionate 200 mg/ml, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,368.00, is a firm fixed-price delivery order with a completion date of June 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a range of pharmaceutical products and medical supplies to the Department of Defense. This contract award does not have a set-aside designation.

Generated 9/19/24, 9:05 AM